WITHDRAWN: Adjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma.
- DOI
- 10.1016/j.hemonc.2016.02.004
- Published
- 2016 Mar 17
- Container
- Hematology/oncology and stem cell therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.hemonc.2016.02.004,
title = {WITHDRAWN: Adjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma.},
author = {Melis MH and Elagwany AMS},
year = {2016},
journal = {Hematology/oncology and stem cell therapy},
doi = {10.1016/j.hemonc.2016.02.004},
url = {https://doi.org/10.1016/j.hemonc.2016.02.004}
}RIS
TY - JOUR TI - WITHDRAWN: Adjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma. AU - Melis MH AU - Elagwany AMS PY - 2016 JO - Hematology/oncology and stem cell therapy DO - 10.1016/j.hemonc.2016.02.004 UR - https://doi.org/10.1016/j.hemonc.2016.02.004 ER -
APA
MH, M., & AMS, E. (2016). WITHDRAWN: Adjuvant chemotherapy followed by interval debulking surgery versus upfront surgery followed by chemotherapy in advanced epithelial ovarian carcinoma.. Hematology/oncology and stem cell therapy. https://doi.org/10.1016/j.hemonc.2016.02.004
Source records
- pubmed · retrieved 2026-09-24T19:02:37.635Z